Condition: IBS - Irritable Bowel Syndrome · Post Infection Syndrome · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational, multicenter, prospective study aimed at characterizing the gut microbiome in patients with post-infectious irritable bowel syndrome (PI-IBS) using whole genome sequencing (WGS). The study will compare microbiome composition and function between PI-IBS patients and two control groups (post-infectious subjects without irritable bowel syndrome -IBS- and healthy controls), with the goal of identifying reproducible microbial signatures and target taxa associated with disease and symptom severity.
This description comes directly from the study's public registry record.
Gianluca Ianiro · +390630155701 · gianluca.ianiro@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Digestive Disease Center, Fondazione Policlinico Univesitario A. Gemelli IRCCS | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07517029